Clinical ResearchLipids and RiskBaseline and On-Treatment High-Density Lipoprotein Cholesterol and the Risk of Cancer in Randomized Controlled Trials of Lipid-Altering Therapy
Lipids and Risk
Under an Elsevier user license
open archive
Key Words
cancer
high-density lipoprotein cholesterol
lipids
randomized controlled trials
Abbreviations and Acronyms
BMI
body mass index
CI
confidence interval
HDL-C
high-density lipoprotein cholesterol
IQR
interquartile range
LDL-C
low-density lipoprotein cholesterol
RCT
randomized controlled trial
Cited by (0)
Dr. Alsheikh-Ali is a recipient of a faculty development award from Pfizer/Tufts Medical Center. Dr. Karas has received speaker and consulting fees from Abbott Laboratories and Merck
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.